BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse upgrades Cadila to outperform
Moraiya facility to be cleared by US drug regulator over next 12-months. FY2018 should represent a steady year for Cadila. US drug regulator is unhappy with implementation of corrective actions.